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ABSTRACT
The ontogenesis of opiate receptor in regions
of rat brain was measured by stereospecific binding
techniques, using 3H-methi:onine-enkephalin (3Hm-met),
an endogenous opioid peptide and 3H-naloxone(3H-nal'),
an opiate antagonist,as the radioligands. The dev-
elopment of opiate receptor showed a caudal to rost-
ral. sequence, and the development of radioimmunoass-
agable B_endorphin in these brain regions parallelled
that of the receptor. However, the ontogenetic time-
tables of opiate receptor as measured by 3H-met and
3H-nal binding were different. This, together with
the findings that the numbers of binding sites for
these two ligands in newborns of the same age were
incongruous And varied in their binding properties,
suggest that there are at least two distinct types
of opiate receptors present in the rat brain.
Furthermore, it was observed that antenatal
exposure to opiates affected t1 development of opiate
receptors in brain regions of newborn rats. Thus,
morphine induced a transient increase in receptor
activity during the early stage of life methadone
had similar effect, but to a less extent naloxone,
a non-addictive opiate antagonist, only had slight
effect. This transient increase in opiate recept-
ors may be related to the neonatal withdrawal sym-
ptoms of babies born to addicted human mothers.
In addition, adult.rats exposed to morphine for
3-4 months revealed lower endorphin levels and
lower B_adrenergic receptor activity in brain. This
finding indicates that B- endorphin. and B-adrenergic
receptor in brain are closely associated with opiate
addiction.
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Over the past ten years, more and more attentions
have been focused on the chemistry of the brain. One
major concern is medical neurochemistry, which deals with
the interrelationship between drugs, neurotransmitter
metabolism, neuropsychiatric and neurological dis-
orders, for example, Parkinson's disease and L-D.opa
therapy (Carlsson, 1970) schizophrenia and catecholamine
metabolism (Carlsson, 1975).' Another stream that has
also drawn much interest is the study of brain develop-
ment. The initial impetus probably originated from the
thalidomide disaster in the early 1960's (McBride, 1961
Lenz, 1961 Weicker, 1965), which led to a heightened
interest of drug effects on development. It is believed
that this area of research not only has practical values,
but also provides insights into the development as well
as normal functions of the brain.
1.2. Biochemical Development of the Brain
It'is now firmly established that the brain of
vertebrates undergoes drastic morphological changes from
2the embryonic neural plate to the complex central nervous
system (CNS) network (Jacobson, 1978). Current research
in the development of the brain ranges from the isolation
and characterization of neurotransmitter systems to single
cell recording and iontophoretic studies in intact neurons
(Lanier et al., 1976). In addition, both fluorescence
histochemical and autoradiographic techniques have been
used for mapping the cell tracks and interconnections
which made up the neuronal networks (01son et al., 1973
Rappoport et al., 1971). These studies indicate that the
cells of the brain do not develop simultaneously but rather,
each region has its own developmental timetable. In
general, there appears to be a caudal to rostral sequence
of development of some of the neurotransmitter systems,
e.g., the noradrenergic and serotone.rgic systems, with
the caudal regions reaching maturity prior to the more
rostral areas (Pscheidt and Himwich, 1966 Lanier et al.,
1976).
Besides, in a variety of species, neurotransmitters
appear early in the life of the embryo, even before the
development of the brain (Buznikov et al., 1964 1968
1970 1972). This preneural presence of neurotransmitters
may be viewed from a neurohumoral perspective, but the
exact role forthis is unknown (Lanier et al., 1976).
3Synaptogenesis is an important stage in brain de-
velopment. It has been shown that prior to synaptogenesis,
the potential postsynaptic membranes may show a selective
sensitivity towards the neurotransmitters of those neurons
which eventually innervate them.- For example, microion-
tophoretic studies by Woodward et al. (1971) has demon-
strated that even before synaptogenesis, cerebellar Purkinje
cells might give specific responses to selective neurotrans-
mitters. This selective sensitivity of postsynaptic mem-
brane may play a role in establishing specific contacts
i. e,., neuronal recognit imn, and it was thought that there
may be an interrelationship between the growth of presynaptic
nerve terminals and the appearance of postsynaptic receptors.
Thus, it has been reported that muscarinic cholinergic
receptor appears before acetylcholine and the choline re-
uptake mechanism in rat striatum (Coyle and Yamamura, 1976)
also, GABA receptor develops earlier than .glutamic acid de-
carboxylase, the biosynthetic enzyme of the GABA in the
brain (Coyle and Enna, 1976).
The recent advent of immunohistochemical and more
refined biochemical techniques has established the presence
of several neuroactive peptides in the CNS (Brownstein,
1977). The possibility that neuropeptides play physiological
roles in neuronal function has long been suggested but only
4recently began to be supported by various lines of evidence
(for review, see Barker, 1977). One class of neuropeptides
- the opioid peptides which distribute unevenly in the
CNS (Yang et al., 1977; Rossier et al., 1977; Bloom et al.,
1978) has been shown to have opiate action (Belluzzi et al,,
04 scher et al., 1976; Lampert at al., 1976) and to bind
stereospecifically to opiate receptors situated in synaptic
membranes (Queen et al., 1976; Simantov et al., 1976).
Until now, the development of opioid peptides and opiate
receptors in brain is by and large unknown.
1.3. Opiates and Opiate Receptor
Morphine, the alkaloid that gives opium its analgesic
actions, is obtained from the milky exudate of the seed
capsules of the poppy plant, Papever Somniferum. This
narcotic has long been used as a painkiller, as an anti-
diarrheal, to induce sleep, to relieve anxiety and to give
rise to a sense of well-being.(Klee, 1977). However, the
mechanism of action of opiates in the CNS remains unknown.
Recently, a large body of pharmacological study sug-
gested that opiates may exert their central actions (e.g.,
euPhoria, analgesia and addiction) by interaction with
a specific neuronal receptor (Beckett and Casy, 1954;
Woods, 1956; Portoghese, 1965; Jacobson, 1972). It was
5Goldstein et al.A1971) who first demonstrated the existence
of stereospecific opiate binding sites in subcellular
fractions of mouse brain using levorphenol, a morphine
congener. Their observation was soon confirmed independently
by others using various labelled agonists and antagonists
(Simon et al., 1973 Terenius, 1973 Pert and Snyder, 1973).
At present, the stereospecificity, saturability, high affinity
of the binding sites and above all, the close correlation
between pharmacological potency and binding affinity for
a large number of opiates have lend strong support to the
idea that these sites are the pharmacologically relevant.
opiate receptors (Stahl et al.,.1977 Simon and Hiller, 1978).
Regional study of the brains of both human (Hiller et
al., 1973) and monkey (Kuhar et al., 1973) revealed that
opiate receptors are not uniformly distributed. In fact,
they are concentrated in areas associated with the limbic
system and the periaqueductal gray areas which play an
important role in opiate-induced euphoria and analgesia.
In particular, the latter brain area has been shown to be
highly re3ponsive sites of morphine analgesia by micro-
injection technique (Jacquet andLajtha, 1974). Furthermore,
opiate receptors are found in all vertebrates studied so
far, but not in invertebrates (Pert et al., 1974). These
findings suggest that opioid binding sites are physiological
6relevant receptors of opiates.
The chemical nature of opiate receptors is not well
understood yet. Roth proteolytic enzymes and protein
modifying agents have been shown to affect stereospecific
binding ofopiates, suggesting a role of proteins in opiate
binding (Simon et al., 1973 Terenius, 1973 Pasternak and
Snyder, 1973). Lipids also play an important role in re-
ceptor activity since binding is inhibited by phospholipase
A though not by phospholipase C. Furthermore, Loh et al..
(1974, 1975) have reported that cerebroside sulfate was
able to bind stereospecifically to labelled opiates and
opiate antagonists, and they suggested that cerebroside
sulfate and possi.jly some other acidic lipids are components
of opiate receptor.(Loh et al., 1978 Craves et al., 1978).
Moreover, treatment of synaptic membrane preparations with
DNase, RNase and neuraminidase have no effect on opiate
binding (Pasternak and Snyder, 1973) which suggested that
DNA, RNA and sialoglycoproteins are not involved in opiate
binding. However, several attempts to solubilize and to
purify the biologically active opiate receptors from syn-
aptic membranes have been unsuccessful (Simon et al., 1972
1975a Walker and Simon, 1977 Simon and Hiller 1978).
71.4 Single or Multiple Receptors for Opiates
Since there are a large number of opiate agonists
and antagonists which differ greatly in their structures,
and yet can bind to opiate receptor in brain with high
affinity, these findings led to a question: whether
there exists a single or multiple receptors for opiate.
According to one school of thought, opiates bind to a
single receptor which may exist in two different con-
formations: one that favours agonist binding in the*ab-
sence of sodium and the other favours antagonist binding
in the presence of sodium (Simon et al., 1975b Creese
et al., 1975). This effect is fairly unique for sodium
ions as it is not observed with other alkali metallic
ions. Manganese and magnesium salts, on the other hand,
can reverse the sodium effect by depressing antagonist
binding and enhancing agonist binding (Pasternak et al.,
1975). These observations led Snyder, Simon and some
others to propose a two-state model of the opiate re-
ceptor whose conformation is allosterically controlled
by sodium ions (Simon and Hiller, 1978 Snyder and Mat-
thysse, 1975)•
There are, however, different views,, As early as
1967, Martin has proposed that there are at least two
8distinguishable analgesic receptors in the CNS, the mor-
phine-type and the nalorphine-type. Naloxone apparently
binds to both types of receptors but morphine binds only
to the morphine-type receptor (Martin, 1967). Recently,
Martin .and co-workers have proposed that there are three
types of opiate receptors- the) receptor which is specific
for morphine, the k receptor for ketocyclazocine, and its
structure analogs, and the6 receptor for allylnormetazocine
(Gilbert and Martin, 1976 Martin et al., Lord et
al. (1976) also proposed a fourth type, the$ receptor,
for opioid peptides. The idea of multiple opiate receptors
rather than a single receptor with two forms has also been
studied in a genetical perspective using different strains
.of mice (Baran et al., 1975 Waterfield et al., 1978). At
present, it appears that the multiple receptor hypothesis
is being favored, It is not clear whether different types
of opiate receptors in the CNS also develop differently.
1.5 Opioid Peptides
The demonstration of neuronal opiate receptors in all
vertebrates from hagfish to man (Simon and Hiller, 1978)
raised another question: why opiate receptors for exogenous
opiates, which are plant alkaloids,'should exist in the CNS
of vertebrates? This initiated the search for endogenous
ligands of opiate receptors., The answer.was provided by
9Hughes et al.(1975) who found that soluble extracts of
mammalian brain could mimick certain effects of alkaloid
opiates, namely the inhibition of neurally evoked con-
tractions of guinea pig ileum and mouse vas deferens. These
findings suggested the presence of endogenous opioid sub-
stances in the CUTS because these two tissues are established
models for testing the actions of biologically active opiates
(Lord et al., 1976). The active factors found in extract3
of mammalian brain have been purified, characterized and
shown to be two pentapeptides they have been named methionine-
enkephalin (met-enkephalin) and leucine-enkephalin. Their




The amino acid sequence of Met-enkephalin was found
to be identical with residues 61-65 of the pituitary hor-
mone j3-lipotropin -LPH), isolated earlier by Li (1964) from
ovine pituitary glands. Recently, a number of opioid
peptides have been isolated and were given the generic name
endorphin (endogenous morphine). For example, Cuillemin
and associates (Guilleman et al., 1976 Ling et al., 1976a)
have isolatedo( -endorphin and r -endorphin from pi.g hypo-
thalamic-neurohypophyseal extracts Cox et al.- (1976) and
Bradbury et-al. (1976a) have independently isolated f -endo-
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rphin from mammalian brains. The amino acid sequence of
I8 -LPII is shown in Fiure 1:














OC -endorphin : sequence 61-76
-endorphin : sequence 61-91
-endorphin : sequence 61-77,
Fig. 1
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It was soon recognized that o( -endorphin corresponds
to the amino acid residues, 61-76 of-LPH, r -endorphin
61-77, -endorphin. 61-91, and met-enkephalin 61-65. This
observation raises a question whether j'_LPH is the pre-
cursor of these opioid peptides. Preliminary evidence seems
to support this view (Bradbury et al., 1976b Chretien et
al., 1976 Ronai et al., 1976 Lazarus et al., 1976 Bloom
et al., 1977) For example, f_LPH, and endorphins had
been shown to be present in the same cells in the anterior
and intermediate lobes of the pituitary gland (Bloom et al.,
1977). Direct evidence, however, has not yet been found
(Klee, 1977 Barchas et al., 1978).
At present, it is known that these opioid peptides
behave like opiates in receptor binding assays and in bio-
assays (Klee, 1977). They also exhibit a variety of opiate
effects when -injected into various brain regions. t'or
example, Wei and Loh (1976) showed that met-enkephalin
and J -endorphin can cause physical dependence when infused
into the periaqueductal gray-fourth ventricular space of
rat brain Loh et al. (1976) demonstrated that -endorphin
is a potent (18-33 times more potent than morphine) analgesic
agent when injected intracerebrally. Bloom et al. (1976)
reported that -endorphin can produce catatonia, hypothermia
and wet-dog shakes when injected into the intracerebrospinal
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fluid compartment. Neurophysiological studies of the
action of morphine, enkephalins and other opioid peptides
showed similar effects on single neurons in many brain re-
gions (Gent and Wolstencraft, 1976 Hill et al., 1976
Bradbury et al., 1976 a,b., Zieglgansberger and Fry, 1976
Frederickson et al 1976 Nicoll et al., 19-17), The firings
of most neurons tested were inhibited by these peptides,
although that of Renshaw Cells were excited (Davis and
Dray, 1976). Furthermore, enkephalins are highly concent
rated in neurons which are the appropriate sites to influence
neuronal activity (Queen et al., 1976 Simantov et al., 1976)
These results indicate that endorphins and enkephalins may
represent a new class of neurotransmitters or neuromodulators
in the CNS (Nicoll .et al.,1977). The development of these
opioid peptides in the CNS, however, is unknown.
1.6 Effects of Opiates on Development
It is known for quite some time that the administration
of certain drugs to pregnant animals may affect both funct-
ional and morphological development of offsprings (Friedler,
1978, Tuchmann-Duplessis, 1977). However, the effects of
most drugs on human and animal fetuses are still unknown.
Although opiate narcotics appear not to cause gross physical
abnormalities in human fetuses, children exposed prenatally
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to opiates are, behaviourally disturbed from birth (Kolata,
1978). Furthermore, infants born to addicted mothers
exhibited the neonatal withdrawal syndrome (Reddy et al.,
1971 Rothenstein at al., 1974). These observations
suggest that opiate narcotics might have exerted their
effects relatively early in the development of the CNS.
Little is known, however, about the possible effects of
opiates on the neurochemical processes during early stages
of differentiation of the brain.
1.7 The Scope of Present Studv
In view of the physiological and pharmacological im-
portance of opiate receptors in neuronal function, the
present study was carried out to elucidate:
1. the developmental pattern of opiate receptors
in rat brain using 3H-methionine-enkephalin, an
endogenous opioid peptide, and 3H-naloxone, an
opiate antagonist as the ligands
2. the regional differences in the development of
opiate receptors
3. the development of 1B-endorphin in brain regions
by radioimmunoassay
4. the effect of antenatal exposure to opiate nar-
cotics on the development of opiate receptors in
14
rat brain and,
5. the effect of chronic opiate treatment on
opiate and other neurotransmitter receptors
in rat brain.
15
CHAPTER II: MATERIALS AND METHODS
2.1 Materials
Tritiated-naloxone (15.2 Ci/mnol) and) H-dihydro-
alprenolol (48.6 Ci/mmol) were obtained from New England
Nuclear Corp., Boston, N.J. Na 1251 (13-17 mCi//o(g Iodine)
and 3H-methionine-enkephalin (31-50 Ci/mmol) were obtained
from the Radiochemical Centre, Amersham, England.
Morphine HC1 was purchased from British Drug House
(BDH), England naloxone was a gift from Endo Lab. Inc.,
N.J.,while methadone was a generous gift of Dr. H. L. Wen
of The Kwong Wah Hospital, Hone Kong.
/3..endorphin was generously provided by Dr. A. A.
Mannian,.N. I. M. H., and met-enkephalin was purchased
from Pierce Chemical Co., U.S.A. Rabbit anti-/- endor-
phin, normal rabbit serum and goat-antirabbit '-globulin
were generously supplied by Dr. K. K. Ho of this Department,
and by Dr. N. Ling, Salk Institute, La Jolla, CA., U.S.A.
Bacitracin, D,L-propanolol, 2,5-diphenyloxazole (PPO)
were'obtained from Sigma 1,4-di-2-(5-phenyloxazolyl)-benzene
(PQPOP) was bought from BDH.
All other chemicals used were of analytical grade
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2.2 Methods
2.2.1 Administration of Opiates
Sprague-Uawley rats inbred in our laboratory
were used in these studies. Animals were maintained
in a temperature-controlled room with alternating
periods of 12-hours light and 12-hours darkness. Pups
were dated zero at birth and litter sizes noted.
Regimens of injections were: groups of female
rats with body weight about 250 g were injected twice
daily with morphine (10 mg/kg, i. p.),
naive male was caged with 2-3 dr: g-treated females.
Subsequent injections of drugs were maintained through-
out pregnancies. At one week. before expected parturi-
tion, females were caged separately. Births were re-
corded within 12 hours of parturition, and litter sizes
noted.
2.2.2 Preparation of Synaptic Membranes
Male and female newborns of various ages were
sacrified by decapitation, and their brains were ra-
pidly removed and dissected into: whole forebrain,
or naloxone (5mg/kg,i.p.), or methadone (5mg/kg,i. p.). Each drug-
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brain stem and cerebellum. For opiate receptor
binding assay, each region was homogenized in Tris-
sucrose (0.32M sucrose in 50 mM Tris buffer, pH
7.7) using a Thomas tissue grinder, type AA or B.
The homogenates were then diluted to 1-2 mg protein
per ml and were used directly for binding assay.
2.2.3 Tritiated-Naioxone Binding Assay
Tritiated-naloxone CH-nal) binding assay was
performed according to Coyle and Pert (1976). Briefly,
portions (0.7 ml) of freshly prepared brain homogen-
ates of various ages were incubated in Tris buffer
(50mM, pH 7.7) at 0°C for 3 hours with 1OnM 3H-nal
in the presence or absence of 10 M morphine without
any sodium added. All samples were assayed in quadri-
plicates. After incubation, the membrane-fractions
were rapidly filtered through the Whatman GF/C glass
fibre paper mounted on a suction apparatus, washed
twice with 4 ml ice-cold Tris buffer (50 mM, pH 7.7).
Filters were dried and shaken thoroughly with 7 ml
scintillation cocktail (1 vol. Triton X-100, 2 vol.
toluene, 0.4% PPO and 0.04/ (w/v) POPOP). Radio-
activity was determined by liquid-scintillation spect-
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rometry (Beckman., Model LS-330) at a counting
efficiency of 50%. Specific 3H-nal binding refers
to the amount of 3H-nal bound in the absence of
added morphine minus the amount of 3H-nal bound in
the presence of 10-5M morphine.
2.2.4 'H-Methionine-Enkephali.n Binding Assay
3H-Methionine-enkephal.in (3H-met) binding
assay was adapted from Siniantov and Snyder (1970).
Briefly, crude brain membranes were first pre-in-
cubated for 5 min at room temperature in the presence
of 0.05 mg of bacitracin per assay tube. Bacitracin
was added to minimize the proteolytic degradation of
3H-met (Simantov and Snyder, 1976). Incubation was
then carried out at 00C for 120 min with 3H-met in
the presence or absence of 10 M morphine. No
sodium ions were added unless indicated. All samples
were assayed in quadruplicate. After incubation,
membranes were harvested as described before. Spec-
ific 3H-met binding was calculated as before.
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2.2.5 Kinetic Analyses of Opiate Bindin
Binding kinetics were performed with a series of
concentrations of radioactive opiates (3H-nal, 0.1-
10 nM 'H-met, 0.1- 5 nM). Data were analyzed by
Scatchard plots (Scatchard et al., 1957).
2.2.6_ -Adrenergic Receptor Binding Assay
For -adr energic receptor binding assay the meth!
of Alexander et al. (1975) was followed using 3H-dihydro-
alprenolol (3H-DHA) as the ligand. Briefly, brain homo-
genates of various regions were centrifuged at 30,000 g
for 10 min using a-Sorvall centrifuge (Model RC2- B).
The pellet was washed twice with 50 mM Tris-HC1 buffer-,
pH 7.7, containing 25 mM MgCl2. The washed membrane
preparation was resuspended in the same buffer at a pro-
tein concentration of 1-2 mg/ml. Aliquots (0.7 ml) of
this partial purified synaptic membranes were incubated
for 15 min at 37°C with 3H-DHA (5 nM) in presence or
absence of 1PM D,L-propanolol, a -adrenergic antagonist.
The incubation was terminated by rapidly filtering the
membrane fraction through the whatnian GF/C glass fibre
circle under pressure. The circle was washed twice
20
with 4 ml of cold Tris buffer. The filter was sub-
sequently dried and radioactivity determined as before.
Specific 3H-DHA binding refers to the difference bet-
ween the total binding of 3H-DHA to the membranes minus
the non-specific binding measured in the presence of
1 uM of D,L-prppanolol.
2.2.7 Radioimmunoassay for B-endorphin
The double antibody radioirnmunoassay described by
Guillemin et al. (1977) was adopted. Brain regions
were dissected as before, boiled in 2 ml 1 N acetic acid
for 15 min and then homogenized. The homogenates were
stored at -20°C and radioimmunoassNys (RIA) for B-endo-
rphin were performed on the supernatant. B-endorphin
was iodinated by the chloramine- T method, as described
by Ling et al. (1976b). Briefly, 10 ,ul of Na125 I was
added to 50 ul of B-endorphin solution (containing 5
4ug B-endorphin) and 10 ul of chloramine- T. The mix-
ture was vortexed for 30 sec and the reaction was stopped
by the addition of 70 ul sodium metabisulfite. After
10 sec of vortex, the mixture was loaded to a degassed
DEAE- Sephadex G 25 column (0.9 x 16 cm), pre-equilibrated
with elution buffer. The column was eluted with 0.02 M
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phosphate buffer, pH 7.5, and iodinated -endorphin
was eluted in the first 3-4 ml.
Determinations for -endorphin by RIA were con-
ducted at 0-4°C. Briefly, aliquots of the samples were
incubated with anti-g -endorphin rabbit serum (final
dilution of 1: 7,500) and with 1251- -endorphin (5,000
cpm/0.1 ml) for 24 hours with RIA buffer (0.01 M phos-
phate saline buffer, pH 7.8 0.033% EDTA 0.5/ BSA).
Normal rabbit serum and goat antirabbit' -globulin
were then added and incubated for another 48 hours. At
the end of the incubation all tubes received 1 mi buffer
and were centrifuged for 20 min at 6,500 g at 4°C. The
supernatants wire aspirated and pellets were counted in
a Beckman gamma counter (Model 4000). Data were analyzed
by the BecSman DP-5000 on-line data reduction system.
2.2.8 Protein Determination
Protein determination was performed by a modified
Lowry's method as suggested by Markwell et al. (1978).
This method eliminates extensive pretreatment (i.e. over-
night alkali digestion) of samples for solubilization.
Besides, it also takes into the account of the inter-
ference given rise by sucrose during protein determination.
22
2.2.9 Data Analysis
Data were analysed by the Student's t test (Camp-
bell, 1974).
23
CHAPTER III: ONTOGiNETIC STUDY OF OPIATE
RECEPTOR IN RAT BRAIN
3. 1. Ontogeny of Opiate Receptor in Different Regions
of Rat Brain
Among the many biochemical changes which accompany
maturation of the brain is a marked change in the neuro-
transmitter receptor activity. Both the receptor binding
activity and the neurotransmitter-sensitive adenylate cy-
clase system have been utilized for studying synaptogenesis.
For example, in rat brain, ontogenesis of adrenergic (Harden
et al., 1977), dopaminergic (Pardo et al., 1977), cholinergic
(Coyle and Yamarnura, 1976), and GABAnergic (Coyle and Enna,
1976) systems have been shown to follow specific patterns
of development.
_Ontogenetic development of opiate receptor in rat
brain has recently been investigated by Coyle and Pert (1976)
using 3H-nal and by Clendeninn et al. (1976) both in rat and
in guinea pig brain using 3H-naltrexone. Both ligands, how-
ever, are opiate antagonists. In view of the findings that
opiate receptors are hetei-enous and that opiate receptors
in.brain may exist in multiple forms, we investigated the
developmental patterns of 3H-met and 3H-pal binding sites in
rhole forebrain,cerebellucn and brain stem. riethionine enke-
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phalin is an endogenous opioid peptide which was first
isolated from rlaminalian brain (Hughes, 197!51). This study
was performed in different brain regions as it has been
proposed that caudal brain structures are phylogenetically
older than rostral brain structures and that they also de-
velop faster than the latter ones (Lanier et al.' 1976).
The result of this study was depicted in Figure 3.1.
In the brain stem, the concentration of 3H-met binding
sites was about 5- fmoi/mg protein during the first week of
life the concentration increast:d rapidly, whereas a sharp
fivefold increase was noticed at day 14 postpartum (p.p.),
and declined to the adult level (about 5 fmol/mg protein) at
day 20 p. p. In the whole forebrain, the concentration was
about 2 fmo?./mg protein in the first week after birth, and
rose gradually to the adult level (about 22 fmole/mg protein)
at day 17 P.P. In the cerebellum, the concentration was
about 1 fmoi/mg protein at day 2 p.p. and a peak concentration
of 5 fmol/mg protein was observed at day 4 p.p. followed by
a sharp decline to the adult level.
The developmental pattern of opiate receptor as measured
by 3H-met binding in the whole forebrain observed in the pre,-
sent study is very similar to those reported by Clendeninn
et al. (1976) and. Coyle and Pert (1976). These investigator. s
measured the development of opiate receptors by stereospecific
binding of labelled opiate antagonists. However, the con-
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Fig. 3.1 Development of opiate receptor in
reg ons of rat brain. Homogenates of-whole
forebrain( 0), brain stem( S),
or cerebellum( 0--0) from rats of various
ages (each about 1-2 mg protein/ml) were incub-
ated with 3H-methionine enkephalin (5 nM) as
described in "Methods." Each point represents
the mean± S. E. of at least 3 separate experi-
ments.
















centration of opiate receptor at birth reported by these in-
vestigators are several folds higher than that measured by
3Hi-met binding. This discrepancy cannot be attributed to ex-
perimental or other errors, as parallel. experiments carried
out with 3H-nal confirmed the data reported by Coyle and Pert
(Table 3. 1 )e
Comparison of-) 11-Met and }H--nal bindingTable 3.1







Data were comparable to those bf Coyle and
Pert (1976).
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Thus, these findings suggest that there are possibly
two distinct types of opiate receptors in rat brains, namely,
the agonist sites measured in the present study and the anta-
gonist sites determined by Coyle acid Pert (1976) and Clendeninn
et' al. 0.976).
3.2. jHI-Naloxone and JH-Methionine-enkephalin Binding Sites
in Different Regions of Rat Brain durinsr Develonment
In view of the findings that the concentration of 3H-met
binding sites _=was different from that of Coyle and Pert (1976)
using 311-nal as the ligand, parallel studies on the develop-
ment of 311-nal and 311-met binding sites were carried out.
Morphine or met-enkephalin was used to displace the 3H-nal
bound,whereas morphine or naloxone was used to displace the
3H-met bound to see if there were any differences between the
ability of different opiates to displace the radioactive li-
and bound (Tables 3.' and 3. 3.).
It is clear from the results (Table 3.2.) that the amount
of 311-nal binding sites is always higher than that of 311-met
binding sites in all, these regions of'the corresponding age.
This difference is particularly obvious in the cerebellum at
day 2 p.p., at this time the concentration of 3H-nal binding
sites was 43.4 friole/mg protein, while that of 311-met remained
at a low concentration throughout the first month of life
(around 3 frimole/mg protein). The high level of 1I-nal binding
29
Table 3.2 Rats were sacrified by decapitation and
brain regions dissected. Stereospecific binding of
3H-methionineenkephalin and 3H-naloxone were deter-
mined as the amount of radioligand bound in the abs-
ence of added morphine minus those in the presence of
10_5M morphine. Each point represents the meant S.E.
of 4 determinations.
Table 3.3 Rats were sacrified by decapitation and
brain regions dissected. Stereospecific binding of
3H-naloxone(3H-nal) refers to the amount of 3H-nal
bound in the presence of 10-5M methionine-enkephalin,
Stereospecific 3H-methionine enkephalin(3H-met) was
determined similarly,except that 105M of naloxone
was used. Each point represents the mean- S.E. of
4 determinations.
30
Table 3, 2 Stereos ec if is binding of 3H-
methionine enkephalin and 3H-
naloxone in regions of develop
ing rat brain.
3H-Naloxone3H-Methionine enkephalin















N.D* 2.5±1.3 2.5±1.9 1.8±1.1 43.40±2.9




17.7±1.2 14.6±1.1 2.8±1.8 17.4±1.3
4.62±0.48
31
Table 3.3 Naloxone inhibition of 3H-methionine enkephalin
binding and methionine enkephalin inhibition of














Stem Cerebellum Stem Cerebetllum





4.5±0.7 9.0±1.5 4.6±2.4 6.9±1.2 N.D.*
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sites was also observed when high concentration (10-:)M) of
met-enkephalin as used as the displacing ligand (Table 3. 3.).
In the brain stem, the amount of 311-nal binding sites
is once again higher than that of 311-met binding sites, and
both peal at the middle of the second weak p.p. The patterns
observed were quite similar when either morphine or met-enke-
phalin was used as the displacing ligand and the same is
true in the whole forebrain. However, comparison- of the
amount of 311-met bound when morphine or naloxone was used as
the displacing ligand indicates that only a certain amount of
311-met binding sites, in all three regions studied ,were avail-
able to naloxone. For example, 1101,'0 at day 11 p.p. in the brain
stem and 25% at day 30 p. p. in the whole forebrain (Table 3.2
and 3.3). No significant difference was observed when either
ligand was used to displace the radiolabelled opiate in the
cerebellum and this may be due to the fact that opiate re-
ceptor concentration in this region is very low, When 3H-nal
binding activity was measured by using either morphine or met-
enkephalin as the displacing ligand, the differences observed
were much greater. For example, in the whole forebrain, only
50°0 of the morphine displaceable 3H-nal binding sites were
available to met-enkephalin and these were increased to about
70% at day 24 p. p. Similar results were observed in the brain
stem and in the cerebellum. These findings suggest that 311-met
and 311-nal bound to different binding sites and that these
binding sites may differ in their developmental timetables.
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To investigate this possibility further, we .examine.d
the binding kinetics of these two ligands in newborns of
various ages. Kinetic analyses of 3H-nal binding in day-5,
day-14, and day-22 pups were performed and the results were
shown in Figure 3.2. From these data, the K D s for 3H-nal
were 1.16, 1.91. and 2.91 nM at days 5, 14 and 22 p.p., res-
pectively while the receptor number increased drastically
from 8.1 to 34.5 to 67 fmoles per mg protein during this time.
Thus, the increase in the amount of 3Hi-nal bound is due to
an incrdase in number of 3H-nal binding sites rather than
changes in receptor affinities.
In order to ascertain whether the difference in amount
of 3H-nal and 3H-met binding sites is due to changes in re-
ceptor number rather than changes in receptor affinity,
scatchard analyses of 3H-met and 3H-nal binding were performed
on the whole forebrain of day 22 rat (Figure 3.3). Similar
studies have also been performed with new borns of younger
ages. However the KDs in these animals cannot be determined
as the amount of 3H-met bound to the synaptic membranes is
very small (data not shown). The K D for 3H-nal binding at
this age was 2.91 nM, while that for 3H-met binding was 2.67
nM which was very similar. The number of receptors,however,
were 20 fmoles per mg protein for 3Hi-met and 67 fmoles per
mg protein for 3H-nal. These findings further substantiated
our conclusion that 3H-met and 3H-nal have different binding
sites and that their developmental timetables are also
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Fig. 3.2 Scatchard analysis of stereospecific
binding of 3H-naloxone (3H-nal) to whole fore-
brain homogenates of newborn rats of day 5 p.p.
(*--*), day 14 p.p.(•--•), and day 22
p.p.( D- D). Naloxone concentrations var-
ying from 0.1 to 10 nM was used in this study.
Each point is a mean of 4 determinations. Re-
suits are plotted according to the method of



















Fig. 3.3. Scatchard analyses of 3H-Met( 0-0) and
311-Iial( 0-0) binding in whole forebrain of
day 22 rats. Concentrations of 3H-met used varied
from 0.1- 5 nM, and for 3H-nal, 0.1- 10 nM.
Each point is a mean of 4 determinations. Re-
sults are plotted according to the method of
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The findings that the ill-nal binding sites are already
present before birth (Coyle and Pert, 1976) and that the
concentration of 3H-nal binding sites were already quite
rich in the whole forebrain of newborn rats (Table 3-1)
suggest that the binding sites for 311-met and 311-nal developed
differently in this region. These together with the obser-
vation that the amount 3H-nal binding sites is always higher
than that of 311-nie t binding sites in all three regions during
the process of receptor ontogeny, and that the difference in
311-met and 311-nal binding .activities in developing rats. is
due to a change in receptor number rather than a change in
receptor affinity, as revealed by Scatchard analyses, suggest
that there are at least two opiate binding sites in brain,
one has higher affinity for niet-enkephalin and the other for
naloxone. It is tentatively concluded that 3H-met binds to
the agonist site while 31I-nalbinds to the antagonist site'.
The concept of multiple opiate receptors, in fact, is not a
new one. Martin (1967) was the first to suggest that opiate
receptors in CNS are not a homogenous population. Lord et all
(1976), rising three different assay systems (brain homogenates,
guinea pi ileum, and mouse vas deferens), had demonstrated
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a heterogenous population of opiate receptors. Recently,
Squires and Braestrup (1978) also demonstrated the pre-
sence of two distinct types of 3H-nal binding sites in
rat brain with different thermo-stability, pH dependence,
affinity constants and regional distribution. These find-
ings, together with the present observations on opiate
receptors development, strongly suggest the existence of
distinct opiate binding sites and failed to support the
sodium.-induced modification of opiate receptor activity
hypothesis which results in an increased affinity for
the antagonist and simultaneously a decreased affinity
for the agonist (Simon and Hiller, 1978 Snyder and Mat-
thysse, 1975)•
Another point worth mentioning is that the concent-
ration of 3H-met binding sites varied greatly in different
brain regions during development. Thus, the receptor in
the cerebellum attains its highest level in the first week
p.p., in the brain stem at the second week p.p. and in
the whole forebrain at the thrid week p.p. and the same
was observed when.3H-nal was used as the ligand. These
findings suggest that the development of 3H-met and 3H-nal
binding sites in rat brain follows a caudal to rostral se-
quences These are similar to the development of catechol-
aminergic (Mabry and Campbell, 1977), GABAnergic (Coyle and
Enna, 1976), and cholinergic (Coyle and Yamamura, 1976) pathways
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whic)l also show a caudal to rostral sequence of development.
In view of the facts that:
1. the cortical cells of the developing rat are
found to be mostly undifferentiated at birth,
with differentiation occuring during the first
three weeks of life (Jacobson, 1978) and,
2. neurons complete their histogenesis by the 21 day
p. p. (I3en jamins and McKhann, 1976),
it would appear that both the 3H-met and the 31H-nal binding
sites are important and integral components of the central
nervous system.
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CHAPTER IV ONTOGENETIC DEVELOPMENT OF
-ENDORPHIN IN REGIONS OF
RAT BRAIN
Recent research in neuronal receptors and their res-
pective presynaptic markets has revealed that there is an
interrelationship between the development of the postsynap-
tic receptors and their respective presynaptic input. For
instance, the muscarinic receptor develops earlier than i-ts.
presynaptic markers: the synaptic acetylcholine contents,
choline uptake and choline acetyltransferase activity in
rat brain (Coyle and Yamamura, 1976) similar results have
also been observed for GABA-nergic system in that the GABA
receptor appears before its presynaptic marker, the glutamic
acid decarboxylase (Coyle and Enna, 1976). The appearance
of postsynaptic receptor before its presynaptic input,
however, is not always the rule. For example, in chick
spinal cord, the high-affinity glycine uptake system.in the
glycine nerve terminal appears before the development of
glycine receptor (Zukin et al., 1975). Furthermore, there
seems to he no discernible correlation between presynaptic
markers and postsynaptic receptors in both chick cholinergic
and rat 8-adrenergic system (Enna et al., 1976 Harden et al.,
1977). In the case of opiate receptor, it remains to be
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established whether there is any relationship between its
development and the ontogenesis of P -endorphin, an endo-
genous opioid peptide. Thus, we investigated the onto-
genesis of P_endorphin in various brain regions and pituitary
by RIA using the double-antibody technique as described by
Guillemin et al. (1977).
The ontogenetic development of(- endorphin in the
whole forebrain is depicted in Figure 4.1. The 1-endorphin
content was about the adult level during the first week
after birth (below 2 ng/mg protein), increased rapidly during
the end of the first week and reached its highest level during
the second week (about 8 ng/mg protein). Thereafter, it
declined gradually to the adult level, which is about 2 ng/mg
protein.
In the cerebellum (Figure 4.2), the -endorphin level
rose to about 50 ng per mg protein, which was about 10 fold
that of the adult, in the first week after birth. This high
level- of P_ endorphin was maintained for about a week and then
declined to the adult level at day 12 p.p.' This was followed
by a small increase during days 19- 24 p.p., and returned
to the adult level again at day 30 p.p.
In the brain stem P_ level remained relatively
constant in the first week p.p. (Figure 4.3). It increased
radually in the second week and peaked at about day 21 p.p,
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Fig. 4. 1 Relationship of endorphin level and
opiate receptor in rat whole forebrain during de-
velopment. Opiate receptor activity
was measured by 3H-methionine enkephalin binding as-
say as described previously. -Endorphin
was determined by radioimmunoassay. Each point on the
endorphin curve represents the meant S.E. of at least
2 separate experiments. (the standard errors for the
opiate receptor curve which have been reported in
Fig. 3.1 have been omitted here.)
Fig. 4.2 Relationship of r-endorphin level and
opiate receptor in rat cerebellum during develop-
ment. Opiate receptor activity
measured by 3H-methionine enkephalin binding assay
as described previously. -Endorphin
was determined by radioimmunoassay. Each point
on the -endorphin. curve represents the meant S.E.
of at least 2 separate experiments. (the standard
errors for the opiate receptor curve have been re-













































then declined to adult level which is about 5 ng/mg protein.
Since pituitary is rich in -endorphin (Bossier et al.,
1977), its -endorphin levels during development were also
determined (Fig. 4.4). It is obvious that pituitary has a
much higher level (1000 ng per pituitary) of -endorphin
during the very early stage of postnatal life. This level
elevated sharply after day 15 p. p. and levelled off at day
21 p.p., at this time the level was about ?500 ng/pituitary
after the third wweek. Compared to the adult level (12740
ng/pituitary), this is about 58% of adult level.
-endorphin levels in various brain regions and in the pit..
uitary of adult rat are comparable to those reported by
Rossier et al. (1977)..
Discussion
The developmental profile of J -endorphin in brain
appears to show a caudal to rostral sequence,. but the pro-
file is less pronounced than that of the opiate receptors.
Comparison of the ontogenesis of opiate receptor and of
-endorphin in the whole forebrain shows a relatively co-
ordinated fashion of development of these two entities.
For example, both of them started to increase in activity
at the end of the first week and both returned to adult
level at about 4 weeks after birth. However, the relation-
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Fig. 4.3 Relationship of endorphin -level and
opiate receptor in rat brain stem during development.
Opiate receptor activity( ®'--®) as measured by.
3H-methionine enkephalin binding assay as described
before. --Endorphin(--) was determined by
radioimmunoassay. Each point on the -endorphin
curve represents the mean± S.E. of at least 2 se-
parate experiments. (the standard errors for the
opiate receptor curve which have been reported in
Fig. 3.1 have been omitted here.)
Fig.4.4 Development of sendorphin in rat whole
pituitary glands. -Endorphin was measured by ra-
dioimmunoassays as described in 'Methods'. Each



































ship between opiate receptors and P -endorphin is not as
close as in other-neurotransmitter systems where postsyn=
aptic receptors develop before the pre-synaptic markers or
vice versa (Coyle and Enna, 1976 Coyle and Yamamura, 1976
Zukin et al., 191)'. This lack of close relationship may
be due to the fact that 3H-met but not radioactive -endorphin
was used in determining the receptor activity during develop-
ment. However,--finding in recent report of Garcin and Coyle
(1976) has shown that there was a strikingly close associ-
ation in the development of endogenous morphine-like.factor
(MLF) and the 3H-nal receptor sites. Upon careful inspect-
ion-, certain small discrepancies were observed and these
may be due to the fact that there investigators used the
3H-nal displacement technique which measures a heterogenous
population of endogenous opioid peptides rather than a specific
opioid peptide as in the present study. In all three brain
regions examined, the levels of -endorphin increased rapidly
during the first week of life but declined at later ages.
This decline in endorphin level may probably be due to
the appearance of peptidases which have been shown to cat-
abolise opioid peptides in the brain (Hambroek et al., 1976
Marks, 1977).
In the pituitary, the development profile of -endorphin
seems to bear no simple relationship to those of the brain
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regions studied, and high level of -endorphin was found
in the pituitary during the whole period of postnatal de-
velopment. Besides, there is no correlation in the time
course between the rise in 'oen dorphin in the pituitary and
in brain. In view of the recent reports that hypophysectomy
did not affect brain endorphin level (Chung and Gold stein,
1976), the present results seem to substantiate the idea
that -endorphin in brain and in the pituitary are probably
derived Tom different sources.
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CITAPTERL V EFFECT OF ANTENATAL EXPOSURE TO
OPIATES ON T111 1' :ENT OF
OPIATE REC EPTOTZS IN RAT I3IZAIN
$. 1. General Introduction
It is known that babies born to addicted mothers
exhibit the so called neonatal withdrawal symptoms,
which are'characterized by strong reflex responses, tremors,
hyperir.ritability, hypertonicity, vomiting, disturbed sleep
as well as excessive and high pitched crying (Nichtenn, 1973
Rothstein and Gould, 19.74 Reddy et al., 1971 Jilson et al.,
1973 Zelson, 1973). Not only are they behaviourally dis-
turbed from birth, they are also tend to be hyperactive and
have short attention span (Kolata, 1978). Since there are
many uncontrollable variables in studying human beings, rats
were used as an animal model in the present investigation to
study this phenomenon. In view of the reports that synapses,
which seem to be the most probable site for opiate receptors
(Synder, 1975 Simon,1976), begin to appear in rudimentary
form at-about the 14th day of the fetal life (Ben jamins and
McKhann, 1976 Davidson, 1977 Eayrs and Goodhead, 1959),
the effects of opiates administered before and during pre-
gnancy on the development of binding sites for 311-met in
.regions of rat brain were investigated. Net-enkephalin, an
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endogenous opiate, has been shown to interact specifically
with opiate receptors in rat brain (Simantov and Snyder,
1976 Tereiiius and Wahlstrom, 1975).
5. 2 Effect of Morphine
The effect of antenatal exposure to morphine on the
development of opiate receptor in the whole forebrain is
shown in Figure 5.1. Exposure to morphine caused a seven-
fold increase in 31i-met binding sites at day 2 pp. This
was followed by a rapid decline to the control level at day
6 p.p. Thereafter, the concentration of opiate receptors
in the offsprings of Vie morphine-treated group increased
gradually after day 18 p.p., the concentr iti.on remained
relatively stable between 15-18 fmoles/mg protein. During
this period, the concentration of opiate receptors never
reached. the control level. However, the level of opiate
receptor returned to the control value after 3 weeks p.p.
Exposure to morphine caused a transient increase of
receptors concentration in day 6 p.p., in the brain stem
(Fig. 5.2). At these tinges, the concentration of receptor
in the offsprings of the morphine-treated group was about
212-fold that of the control. However, by days 8-10 p.p.,
the concentration of opiate receptor in the drug-treated
group has fallen below that of the control group and never
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Fig. 5.1 Effect of antenatal exposure to
morphine on the development of opiate re-
ceptors in rat whole forebrain. Female
rats were treated with morphine (10mg/Kg,i.p.
twice daily) before and during pregnancy.
Newborns of various ages 1born to morphine-
treated(0--0) or naive (0--0) mothers
were sacrified. Homogenates of whole fore-
brain of each newborn were then incubated
with 3H-methionine enkephalin as described
in Methods. Each point represents the
meant S.E. of at least 3 separate experiments.
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Fig. 5.2 Effect of antenatal exposure to
morphine on the development of opiate re-
ceptors in rat brain stem. Female rats
were treated with morphine(10 mg/Kg,i.p.,
twice daily) before and during pregnancy.
Newborns of various ages born to morphine-
treated
brain stem of each newborn were incubated
with 3H-rTiethionine enkephalin as described
in Methods. Each point represents the
mean±S.E. of at least 3 separate experiments.
p 0.01 and **p 0.001 when compared to
the corresponding control.
or naive



















reached the control level which peaked at day 10-14 p.p.
In the cerebellum of the morphine-treated group, there
was a transient 5-fold increase in receptor concentration
at day 5 P.P. (Fig. 5.3).
5.3 Effect of Methadone
Methadone has been widely used in recent years as a
substitute for addictive opiate narcotics,both in Hong Kong
and in elsewhere thus, it would be natural to investigate
the effect of this compound. Methadone is a weaker agonist
than morphine, and its effects on addicts and fetus are not
well documented. Research ,.v-ork on human is difficult to
interpret owning to the fact that addicted mothers on methadone-
maintenance always take opiate narcotics and other drugs-in
addition to their legitimate methadone dosage. Thus, animal
model simplifies the situation and the results obtained are
described below.
As can be seen in Figure 5.4, exposure to methadone
shifted the peak of opiate receptor concentration to day 28
P.P. from day 22 p.p. in the control. From day 14 p.p. onwards,
the concentration of opiate receptor in the offspring of the
methadone-treated group increased gradually after day 26 p..p.
the concentration remained relatively stable between 14-20
fmoles per mg protein. During this period, the concentration
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Fig- 5.3 Effect of antenatal exposure to
morphine on the development of opiate re-
ceptors in rat cerebellum. Female rats
were treated with morphine(lOmg/Kg,i.p.,
twice daily) before and during pregnancy.
Newborns of various ages born to morphine-
txwcated
mothers were sacrified, Homogenates of
cerebellum of each newborn were incubated
with 3H-methionine enkephalin as described
in the Methods. Each point represents
the mean± S.E. of at least 3 separate
experiments.




















Fig. 5.4 Effect of antenatal exposure to
methadone on the development of opiate re-
ceptors in rat whole forebrain. Female
rats were treated with methadone(5mg/Kg,i.p.
twice daily) before and during pregnancy.
Newborns. of various ages tern to methadone
treated(.---)ornaive(Q.o)
mothers were sacrified. Homogenates of
whole forebrain of each newborn were then
incubi ted with 3H-methionine enkephalin as
described in Methods. Each point repre-
sents the mean+ S.E. of at least 3 separate
experiments.



















was lower than the control level.
Exposure to methadone did not cause an increase of
opiate receptor in the brain stem during the first week
as is in the case of morphine (Fig.5.5 and 5.2 ). The
concentration of receptor in the brain stem of the methadone
treated group remained relatively low (below 5 fmoles/mg
protein) in the first two weeks p.p., rose gradually and
peaked at day 18 p.p. (about 12 fmoles/mg protein). There-
after, the level was below that of the control group.'
In the cerebellum, the concentration of opiate receptor,-
in the offsprings of the methadone-treated group had a trans-
ient three-fold increase at day 8 p.p. (Fig. 5.6 ),while. in
the morphine-treated group the transient increase occurred at
day 5 p, p.
5.4 Effect of Naloxone
The observation that both morphine and methadone affect
the development of opiate receptors in rat brain prompted us
to investigate whether antenatal administration of an opiate,
antagonist would affect the development of opiate receptors.
The antagonist chosen for this study is naloxone. Naloxone
is believed to be a pure antagonist with the least agonist
activity (Snyder, 1977) moreover, this opiate is non-addictuve
and binds to opiate receptors with great specificity (Snyder,
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Fig. 5.5 Effect of antenatal exposure to
methadone on the development of opiate re-
ceptors in rat brain stem. Female rats
were treated with methadone(5 mg/Kg.i.p.,
twice daily) before and during pregnancy.
Newborns of various ages born to methadone-
treated
mothers were sacrified. Homogenates of
brain stem of each newborn were incubated
with 3H-methionine enkephalin as described
in Methods. Each point represents the
mean± S.E. of at least 3 separate experiments.




















Fig. 5.6 Effect of antenatal exposure to
methadone on the development of opiate re-
ceptor in rat cerebellum. Female rats
were treated with methadone(5 mg/Kg,i.p.,
twice daily) before and during pregnancy.
Newborns of various ages born to methadone-
treated
mothers were sacrified. Homogenates of
cerebellum of each newborn were incubated
with 3H-methioni.ne enkephalin as described
in. the Methods O Each point represents
the meant S.E. of at least 3 separate
experiments.





















As shown in Fig. 5.7, exposure to naloxone did not
cause the transient increase in opiate receptor in the ifliole
forebrain at day 2 p.p. as in the case of morphine-treated
group. Besides, the concentration of opiate receptor was
only about 2-3 fmoles/mg protein in the first 10 days after
birth. The concentration increased gradually to the adult
level (about 20 fmoles/mg protein) at day 20 p.p. During
the first month after birth, the developmental pattern in
the offsprings of the naloxone-treated group was similar to
that of the control group, except a transient peak was ob-
served at day 26-28 p.p., which is significantly higher than
the control.
Fig. 5.8 shows the effect of antenatal exposure to nal-
oxone on the concentration of 3H-met binding sites in the
brain stem. Naloxone caused a transient 5-fold increase in
receptor concentration in day 6 p.p., compared to the control.
However, by day 8-10, the concentrations of receptor in both
the naloxone and the morphine-treated groups fell below that
.of control and did not reach the control value which peaked
at days 10-1k1 p.p.
In the cerebellum, the concentration of opiate receptor
in the naloxone-treated group was similar to that of the con-
trol, which was below 5 fmole/mg protein (Fig. 5.9), and no
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Fig. 5.7 Effect of antenatal exposure to
naloxone on the development of opiate re-
ceptors in rat whole forebrain. Female
rats were treated with naloxone(5mg/Kg,i.p.,
twice daily) before and during pregnancy.
Newborns of various ages born to naloxone
treated
mothers were sacrified. Homogenates of
whole forebrain of each newborn were then
incubated with 3H-methionine enkephalin
as described in Methods. Each point
represents the mean± -g: E. cif at least 3
separate experiments.



















Fig. 5.8 Effect of antenatal exposure to
naloxone on the development of opiate re-
ceptors in rat brain stem. Female rats
were treated with naloxone(5 mg/Kg, i.p..,
twice daily) before and during pregnancy.
Newborns of various ages born to naloxone
treated
mothers were sacrified. Homogenates of
brain stem of each newborn were incubated
with 3H-methionine enkephalin as described
in Methods. Each point represents the
meant S.E. of at least 3 separate experiments.























Fig. 5.9 Effect of antenatal exposure to
naloxone on the development of opiate re-
ceptors in rat cerebellum. Female rats
were treated with naloxone(5mg/Kg, i.p.,
twice daily) before and during pregnancy.
Newborns of various ages born to naloxone
treated
mothers were sacrified. Homogenates of
cerebellum of each newborn were incubated
with 3H-methionine enkephalin as described
in the Methods, Each point represents
the mean ±S.E. of at least 3 separate
experiments.




















transient increase was observed during the first two weeks
of life.
5.5 Effect of Antenatal_ Exposure to Opiates on the Litter
Sizes
In addition, it is worthwhile to mention that the litter
sizes of the female rats exposed to morphine, but not to nal-
oxone or methadone, before and during pregnancy were signifi-
cantly reduced (Table 5.1). This is in agreement with the
results reported in the literature (Friedler, 1978 Friedler
and Cochin, 1972). Brain weights, however, are not significant-
ly different in the three grclups for all regions studied
(data not shown).
5.6 Discussion
Marked differences were observed in the development of
opiate receptors of progeny exposed in utero to morphine.
Most pronounced of these changes are: morphine administration
induces a transient increase in the concentration of opiate
receptors in the first week p. p. in all three brain regions
of the offspring besides, in the subsequent three weeks
p.p., drugs lowered the concentrations of opiate receptors in
the whole forebrain and in the brain stem of the offspring
but has no effect in the cerebellum. These observations
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(Mean 1 S. E.)
8None (control g. 6= 2.2
4.9 --:2.8*Morphine 8
Naloxone 8 9.1= 3.7
Methadone 9.3 1 1.53
Female rats were treated with morphine, naloxone
or methadone before and during pregnancy as described in
Methods.
* p/,0.001 compared to "None"
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clearly indicate the opiate administration before and dur-
ing pregnancy affects the development of opiate receptors
in the offsprings.
In the case of methadone, it is interesting to note
that there are many similarities between the developmental
patterns of opiate receptors in the progenies born from
morphine- or methadone-treated mothers, e.g., both caused
a general decrease of receptors activity in the whole fore-
brain during the first month of life when compared to the
control both caused a transient increase in receptor in the
cerebellum in the early stage of development,but morphine
seems to be more potent. The only major difference between
these two opiate agonists is that rnethade:r.e does not cause
an increase of opiate receptor in the first week in the brain
stem. Besides, the development of opiate receptors in all
three regions studied seems to be delayed when compared to
the control group. These findings are not surprising as
opiates are believed to be behavioural teratogens in human
(Kolata, 1978), and that prenatal exposure to opiates may
affect the development of subsequent progeny in human (Nich-
tenn, 1973 Rothstein, 1974), as well as in rodents (Davis
and Lin, 1972 O'Callaghan and Holtzmann, 1976).
Since adults under methadone-treatment can produce a
withdrawal symptom similar to that of heroin addiction which
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consists of weakness, anxiety, anorexia, insomnia, sweating
and abdominal discomfort (Goodman and Gilman, 1960), it is
natural to ask whether methadone will produce the neonatal
withdrawal symptom. Clinical reports concerning the passive
addiction of children born to methadone-maintained mother
are contradictory ('Tallach et al., 1969 Reddy et al., 1971
H. Tuchmann-Duplessis, 1977). This conflict is probably due
to the fact that addicted mothers usually took other drugs-
as well. The present study demonstrated that methadone affects
the development of opiate receptors in rat brain. Moreover,
it is interesting to find that the offsprings of methadone-
treated group had significantly lower endorphin content in
the pituitary during the process of development (Fig. 5.10).
Opiate receptor developmental patterns of the. offsprings
of naloxone-treated group was on the whole similar to that of
the control, with exception that a transient increase in
concentration of 311-met binding sites in the brain stem was
observed at day 6 p.p. The possible significance of this is
unknown. Since naloxone is a non-addictive opiate though
binds to opiate receptor in a specific manner, it is not
surprising to find that this antagonist does not affect the
litter sizes.of treated rats, nor does it affect the de-
velopment of opiate receptors in the newborns of naloxone-
treated mothers to the same.extent as those of morphine- or
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Fig. 5.10 Effect of antenatal exposure to
methadone on f-endorphin levels in rat
pituitary during development. Female rats
were-treated with methadone(5 mg/Kg,,i.p.,
twice daily) before and during pregnancy.
Newborns of various ages born to methadone-
treated
mothers were sacrified. -Endorphin was
extracted and assayed as described before.
Each point represents the mean± S.C. of
at least 2 separate experiments.



















methadone-treated mothers. This observation seems to
suggest that neonatal withdrawal symptoms may be related to
the transient increase in opiate receptor activity in brain
in neonates born to addicted mother during early stage of life.
Opiates have been shown to be able to cross both the placental
and the blood-brain barriers (Kupferberg and Way, 1963 Sanner
and Woods, 1965 Blane and -Dobbs, 1961 Yeh and Woods, 1970
Jo'hannesson et al., 1972) and so its effect on opiate re-
ceptor development, as well as increases in perinatal mort-
ality and growth retardation (Friedler 1972 1978) seems not
unexpected.
Earlier, Coyle and Pert (1976) reported that aggressive
treatment with morphine or naloxone during the last week of
pregnancy failed to alter the stereospedific binding of 311-
nal in brain homogenates of morphine and naloxone-treated
rats. Since treatment with opiate during the last week of
pregnancy failed to alter the binding of 3}I-nal, while treat-
ment with opiate before and during pregnancy causes a clear
alteration of opiate receptors in brain, it appears that
opiate might have exerted its pharmacological effect on the
development of opiate receptors in the CNS at the early stage
of differentiation. 1n- thi s regard, it is interesting to
note that Friedler(19781 had recently reported that pregest-
ational administration of opiate affects the development of
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the progeny. In view of the present finding, it seems
that alterations in the development of the 311-met binding
sites in the CNS may play a role in the passive addiction
of rat fetuses. Based on the homologies in the development
of the CNS of rat and human (Olson et al., 1973), it would
appear that the neonatal withdrawal symptoms of infants
born to addicted mother may be related to the alterations
in the concentration of 3H-met binding sites in brain ob-
served in the first month after birth.
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CHAPTER VI: GENERAL CONCLUSION
Using JH-met and 3H-'nal as the radioligands, the
developmental patterns of opiate receptors in differ-
ent regions of rat brain have been elucidated. The
present study revealed that the development of opiate
receptors, like many other neuronal receptors, followed
a caudal to rostral sequence. Comparison of the
developmental timetables of 3H-met and 3H--nal binding
sites in Drain indicated that they are different and
the possibility of multiple receptors in brain at the
early stage of life was suggested. This finding is
in agreement with several reports or. the existence
of multiple opiate receptors in adult rat brain
( Lee et al„1975 Lord et al.,1976 Martin et gl.,
1976). Furthermore, kinetic analyses of opiate
receptors in developing rat brains showed that the
increase in opiate binding activity during develop-
ment was mainly due to an increase in receptor num-
bers rather than changes in receptor affinity for
different ligands used.
The developmental profile of -endorphin seem
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to parallel to that of opiate receptors and they also
seem to follow a caudal to rostral sequence of deve-
lopment. Another point of interest is.that the onto-
geny of endorphin in various brain regions bore
no simple relationship to the development of this
endogenous opioid peptide in the pituitary. This
is in agreement with recent evidence that endorphin
in brain and in pituitary are probably originated
from different sources(Cheung and Goldstein,1976).
Concerning the effect of chronic opiate treat-
ment on the development of opiate receptors, it
was fqund that morphine induced a transient increase
in receptors in the whole forebrain, the cerebellum,
and the brain stem. The effect of methadone was simi-
lar to*that of morphine, but was less prominent. Nal-
oxone, which is believed to be a pure,non-addictive
opiate, affects the development of opiate receptor in
the brain stem only. So, it seems that changes in
the development of 3H-met, binding sites in the CNS
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might be related to the neonatal withdrawal sym-
ptoms in babies born to addicted mothers. Further-
more, chronic opiate exposure during pregnancy
.not only affects opiate receptor development in the
infants,but also has effects on certain neurochem-
ical processes in adults. Preliminary observations
suggest that chronic morphine administration reduced
the endorphin contents in the three regions stud-
iedi (Tahl a 6.1).. Though f--- endorphin is closely
associated with analgesia, tolerance and dependence,
the possible significance of this observation remains
to ba elucidated. Moreover,the -adrenergic receptor,
as.measured by 3H-DHA binding,was also reduced
(Table 6.2). In view of the recent studies that
noradrenaline(NA) and adenosine-3',5'-monophosphate
(CAMP) may be involved in the actions of opiate
narcotics(Blasig et al.,1973 Buxbaum et al.,1973)
and that opioid peptides inhibited NA-stimulated
CAMP formation in rat cerebral cortex and hypo-
thalamus(Tsang et al.,1978),it seems likely that
chronic opiate addiction can alter NA receptor
activity in mammalian brains.
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Table 6e1 Effect of chronic morphine-
treatment-on- le-
vels in various rat brain regions
Whole Forebrain Cerebellum Brain Stem
Treatment
(ng/mg protein) ing/mg protein) (ng/mg protein)
None 1.81=0.08 (3) 3.6O-O71 (3) 5.3210.55 (3)
(control,
Morphine 0.90=0.11*(4 2.8o=o.45*(4)1.35¢0.41* (4)
Rats were treated with morphine (10mg/Kg,i.p.,
twice daily) for 3-4 months. They were sacrified
by decapitation and brain regions dissected.
-endorphin levels in different regions were de-
termined by radioimmunoassays as described in the
Methods. the numbers in parentheses refer to
numbers of individual experiments.
p,0.002 when compared to the corresponding
control.
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Table 6.2 Effect of chronic morphine-treatment
on -adrener is receptor activi
in various rat brain regions
Whole forebrain Cerebellum Brain Stem
Treatment
3H-DHA bound 3H-DHA bound 3H-DHA bound
(fmol/mg protein (fmol/mg protein) (fmol/mg protein)
None 43.68±4.o4. (3)58.24±7.39 (3) 17.86± 1.88 (3)
(control]
Morphine 9.5310.33G(4)60.7117.60 (4) 21.53±1.40*(4)
Rats were treated with morphine (10 mg/Kg i.p.,
twice daily) for 3-4 months. They were sacrif-
ied by decapitation and brain regions dissected.
-adrenergic receptors were assayed by 3H-dihy-
droalprenolol (3H-DHA) binding as described in
Methods. the numbers in parentheses refer to
numbers of individual experiments.
*p 0.001 when compared to the corresponding
control.
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Table 6.2 Effect of chronic morphine-treatment
on -adrenergic receptor activity,
in various rat brain regions
Thole forebrain Cerebellum Brain Stem
Treatment
3H-DHA bound 3H-DHA bound 3H-DHA bound




Rats were treated with morphine (10 mg/Kg i.p.,
twice daily) for 3-4 months. They were sacrif-
ied by decapitation and brain regions dissected.
-adrenergic receptors were assayed by 3H-dihy-
droalprenolol (3H-DHA) binding as described in
Methods". The numbers in parentheses refer to
numbers of individual experiments.
*p/,0.001 when compared to the corresponding
control.
88
CHAPTER VII: CLAIM OF ORIGINALITY
1. The ontogenesis of opiate receptors in whole fore-
brain, cerebellum and brain stem of the developing
rats was measured by the stereospecific binding of
3H-met and 3H-nal. Opiate receptors development
was found to follow a caudal to rostra]. sequence:
a transient..-peak was observed at day 4 p.p. in the
cerebellum a hump was observed at days 8-17 p.pe
in the brain stem while in the whole forebrain
the adult density was-reached at day 17 p. p.
2. 3H-met and 3H-nal binding sites seem to develop accord.
ing to different timetables, with 3H-nal binding sites
appear before the 3H-met binding sites. Kinetic an-
alyses showed that they have similar K D s but differ
in receptor numbers. The possibility of multiple
opiate receptors was substantiated.
3. The developmental profiles of -endorphin in whole
forebrain, cerebellum and brain stem were investigated.
The appearance of -endorphin in developing rat brain
also seems to follow a caudal to rostral sequence.
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Interrelationship between endogenous ligands and
opiate receptor development has been discussed.
4. The developmental profile of -endorphin in the
pituitary bore no simple relationship to those of
brain -endorphin.
5. Administration of opiates before and during pregnancy
significantly altered the regional development of 3H-
met binding sites in the brains of the offsprings.
6. Morphine administered to female rats before and during
pregnancy induced an increase in opiate receptors in
brain regions of the offspring. This increase might
probably be related to the neonatal withdrawal symptoms,
7. For the offsprings of methadone-maintained mothers,
opiate receptor development in different brain re-
gions was affected. The -endorphin content in the
pituitary was also significantly. altered.
8. Naloxone, a non-addictive opiate antagonist, showed
little effects on opiate receptor development except
in the brain stem.
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9. The litter sizes of the morphine-treated group,
but not of the methadone- or naloxone-treated group
were significantly reduced when compared to the
control group.
10. The -adrenergic receptor and endorphin contents
in three brain regions of mothers under chronic
morphine treatment were significantly decreased.
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